Creating a blood test for herpes simplex viruses 1 and 2.
SBIR Topic 133: Development of a Serological Test for Herpes Simplex Types 1 and 2 Infections
This study is working on a new blood test to help doctors quickly find out if someone has a herpes infection, which could make it easier to manage and treat the condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Immport Therapeutics, INC. NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project ID | NIH-11203298 on NIH RePORTER |
What this research studies
This research focuses on developing a serological test to detect infections caused by Herpes Simplex Virus types 1 and 2. The approach involves creating a diagnostic tool that can identify these viruses through a simple blood test, which could help in early detection and management of the infections. By improving diagnostic capabilities, the research aims to provide healthcare providers with better tools to diagnose and treat patients effectively.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who are at risk of or currently experiencing symptoms related to herpes simplex virus infections.
Not a fit: Patients who have already been diagnosed and are receiving effective treatment for herpes simplex infections may not benefit directly from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and accessible testing for herpes simplex infections, improving patient care.
How similar studies have performed: Previous research has shown promise in developing serological tests for viral infections, indicating potential success for this approach.
Where this research is happening
Irvine, United States
- Immport Therapeutics, INC. — Irvine, United States (Active)
Researchers
- Principal investigator: Camerini, David — Immport Therapeutics, INC.
- Study coordinator: Camerini, David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.